News

Claude 3, Gemini, Midjourney, and more with 1min.AI - now just $79.97 (reg. $540). AI is a circus, but you don't have to be its monkey. Between monthly fees, login juggling, and paying extra to access ...
With the new partnership, Bragi will offer headphone vendors the ability to access a GPT-based assistant via a button press or a wake word.
Colorado voters could weigh in on initiatives regarding immigration enforcement, college admissions, delivery fees and more.
The implications are far reaching. DeepSeek’s breakthrough prompts a complete rethinking of how AI infrastructure is ...
This isn’t the first time that Sam Altman has acknowledged his fears over the growth of the AI industry. OpenAI has the likes of Google and Microsoft snapping at its heels and Altman probably knows ...
Global X’s Uranium ETF has 48 holdings, and all of them are involved in some facet of the nuclear industry. Read why URA is a ...
Z.ai’s new open-source models rank third globally, as the firm eyes a Hong Kong IPO and navigates around U.S. export controls ...
That's the question on everyone's mind these days. While OpenAI hasn’t confirmed an official launch date, sources close to ...
OpenAI's ChatGPT-5 could drop in the coming days, and it could be one of the best models from the Microsoft-backed startup.
Use of glucagon-like peptide-1 receptor agonists might be beneficial for patients with some cancers, research suggests.
Explore the groundbreaking Qwen 3 Coder, an AI tool automating coding tasks and outperforming GPT-4.1 with cutting-edge ...
For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with lower all-cause mortality than dipeptidyl peptidase-4 inhibitor ...